RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp to Present at Wilsons Healthcare IT Conference, page-2

  1. 17,310 Posts.
    lightbulb Created with Sketch. 1331
    Great stuff... the 'long wait' is finally over.

    "ResApp also advises that the startup of its US clinical study, SMARTCOUGH-C, is
    progressing well with recruitment to begin this quarter. Details of the study are now
    available on the US National Institutes of Health clinical trials database at
    www.clinicaltrials.gov  (NCT02973282). Institutional review board approvals  are in
    place, and Site Initiation Visits at the main sites and their multiple satellite sites will
    take place shortly, during which clinical staff will be trained on the  final  approved
    protocol. The Company expects rapid recruitment given the size of the participating
    hospitals and the onset of winter in the US when there  is  a high prevalence of
    respiratory disease."


    We are now in business & now we all have an understanding of what needs to happen prior to the enrolment of patient #1 & the rumours about the trials not going ahead & the other crap bandied about on this website can cease...!

    Also - the presentation on Wednesday to 40 Insto investors who are "invite only" and "who are new
    to healthcare IT and e-health investment opportunities and looking to gain a more in-
    depth understanding of the sector.
    " is extremely exciting.

    After a long winter (no pun intended) it seems like we will resume the uptick & the first target will be to make new all-time highs.
    Last edited by Wise_One: 28/11/16
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.